Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andersen

Showing results (271-280 of 530) with videos related to

Pageof 53
Sort By:
The Journal of Biological Chemistry|March 19, 2004
Identification, expression, function, and localization of a novel (sixth) isoform of the human sarco/endoplasmic reticulum Ca2+ATPase 3 geneRégis Bobe, Raymonde Bredoux, Elisabeth Corvazier, et al.
Frontiers in Immunology|November 29, 2019
Corrigendum: Site-Specific DC Surface Signatures Influence CD4<sup>+</sup> T Cell Co-stimulation and Lung-HomingDavid Pejoski, Marie Ballester, Floriane Auderset, et al.
NPJ Vaccines|January 30, 2020
Parenteral vaccination protects against transcervical infection with <i>Chlamydia trachomatis</i> and generate tissue-resident T cells post-challengeNina Dieu Nhien Tran Nguyen, Anja W Olsen, Emma Lorenzen, et al.
Infection and Immunity|April 23, 2004
Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovisKonstantin Lyashchenko, Adam O Whelan, Rena Greenwald, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2015
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approachFabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2016
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profileSigne Tandrup Schmidt, Swapnil Khadke, Karen Smith Korsholm, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 13, 2008
NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01Dennis Christensen, Morten Allesø, Ida Rosenkrands, et al.
Plos One|August 12, 2024
Is something rotten in the state of Denmark? Cross-national evidence for widespread involvement but not systematic use of questionable research practices across all fields of researchJesper W Schneider, Nick Allum, Jens Peter Andersen, et al.
Human Vaccines|December 24, 2010
First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responsesTom H M Ottenhoff, T Mark Doherty, Jaap T van Dissel, et al.
Immunology|February 17, 2007
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomesKaren Smith Korsholm, Else Marie Agger, Camilla Foged, et al.
Pageof 53

Showing results (271-280 of 530) with videos related to

Sort By:
Pageof 53
The Journal of Biological Chemistry|March 19, 2004
Identification, expression, function, and localization of a novel (sixth) isoform of the human sarco/endoplasmic reticulum Ca2+ATPase 3 geneRégis Bobe, Raymonde Bredoux, Elisabeth Corvazier, et al.
Frontiers in Immunology|November 29, 2019
Corrigendum: Site-Specific DC Surface Signatures Influence CD4<sup>+</sup> T Cell Co-stimulation and Lung-HomingDavid Pejoski, Marie Ballester, Floriane Auderset, et al.
NPJ Vaccines|January 30, 2020
Parenteral vaccination protects against transcervical infection with <i>Chlamydia trachomatis</i> and generate tissue-resident T cells post-challengeNina Dieu Nhien Tran Nguyen, Anja W Olsen, Emma Lorenzen, et al.
Infection and Immunity|April 23, 2004
Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovisKonstantin Lyashchenko, Adam O Whelan, Rena Greenwald, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2015
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approachFabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2016
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profileSigne Tandrup Schmidt, Swapnil Khadke, Karen Smith Korsholm, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 13, 2008
NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01Dennis Christensen, Morten Allesø, Ida Rosenkrands, et al.
Plos One|August 12, 2024
Is something rotten in the state of Denmark? Cross-national evidence for widespread involvement but not systematic use of questionable research practices across all fields of researchJesper W Schneider, Nick Allum, Jens Peter Andersen, et al.
Human Vaccines|December 24, 2010
First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responsesTom H M Ottenhoff, T Mark Doherty, Jaap T van Dissel, et al.
Immunology|February 17, 2007
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomesKaren Smith Korsholm, Else Marie Agger, Camilla Foged, et al.
Pageof 53